Respiratory Care Services, King Khalid Hospital, Najran, Saudi Arabia.
Respiratory Care Department, Prince Sultan Military College of Health Sciences, Dhahran, Saudi Arabia.
Ann Thorac Med. 2015 Jan-Mar;10(1):16-24. doi: 10.4103/1817-1737.146855.
Non-invasive ventilation (NIV) has been widely supported in the past two decades as an effective application in avoiding the need for endotracheal intubation (ETI) and reducing associated mortality in acute hypoxemic respiratory failure (AHRF) patients. However, the efficacy of NIV in AHRF patients, non-related to chronic obstructive pulmonary disease (COPD) and trauma is still controversial in the field of medical research. This retrospective study aimed to evaluate the efficacy of NIV as an adjunctive therapy in non-COPD and non-traumatic AHRF patients. Data of 11 randomized control trials (RCTs), which were conducted between 1990 and 2010 to determine the efficacy of NIV in non-COPD and non-traumatic AHRF patients, were reviewed from the PUBMED, MEDLINE, Cochrane Library, and EMBASE databases. Parameters monitored in this study included the ETI rate, fatal complications, mortality rate of patients, and their ICU and hospital duration of stay. Overall results showed a statistically significant decrease in the rate of ETI, mortality, and fatal complications along with reduced ICU and hospital length of stay in non-COPD and non-trauma AHRF patients of various etiologies. This systematic review suggests that non-COPD and non-trauma AHRF patients can potentially benefit from NIV as compared with conventional treatment methods. Observations from various cohort studies, observational studies, and previously published literature advocate on the efficacy of NIV for treating non-COPD and non-traumatic AHRF patients. However, considering the diversity of studied populations, further studies and more specific trials on less heterogeneous AHRF patient groups are needed to focus on this aspect.
在过去的二十年中,无创通气(NIV)已被广泛应用,可有效避免气管插管(ETI)的需要,并降低急性低氧性呼吸衰竭(AHRF)患者的相关死亡率。然而,NIV 在非 COPD 和非创伤性 AHRF 患者中的疗效在医学研究领域仍存在争议。本回顾性研究旨在评估 NIV 作为非 COPD 和非创伤性 AHRF 患者辅助治疗的疗效。从 PUBMED、MEDLINE、Cochrane 图书馆和 EMBASE 数据库中检索了 1990 年至 2010 年间进行的 11 项随机对照试验(RCT)的数据,以确定 NIV 在非 COPD 和非创伤性 AHRF 患者中的疗效。本研究监测的参数包括 ETI 率、致命并发症、患者死亡率以及 ICU 和住院时间。总体结果显示,非 COPD 和非创伤性 AHRF 患者的 ETI 率、死亡率和致命并发症发生率均显著降低,且 ICU 和住院时间缩短。对于各种病因的非 COPD 和非创伤性 AHRF 患者,NIV 可能比传统治疗方法更有效。来自各种队列研究、观察性研究和已发表文献的观察结果均支持 NIV 治疗非 COPD 和非创伤性 AHRF 患者的疗效。然而,考虑到研究人群的多样性,需要进一步研究和更具体的试验来关注这一方面,这些试验应针对异质性较低的 AHRF 患者组。